Cargando…

Viral Fitness of Baloxavir-Resistant Recombinant Influenza B/Victoria- and B/Yamagata-like Viruses Harboring the I38T PA Change, In Vitro, Ex Vivo and in Guinea Pigs

Seasonal influenza A and B viruses may cause severe infections requiring therapeutic interventions. Baloxavir, the latest antiviral drug approved against those infections, targets the endonuclease activity encoded by the polymerase acidic (PA) protein. While appearing effective at cessation of viral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saim-Mamoun, Amel, Carbonneau, Julie, Rhéaume, Chantal, Abed, Yacine, Boivin, Guy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223713/ https://www.ncbi.nlm.nih.gov/pubmed/37317069 http://dx.doi.org/10.3390/microorganisms11051095

Ejemplares similares

Generation and Characterization of Drug-Resistant Influenza B Viruses Selected In Vitro with Baloxavir Acid
por: Saim-Mamoun, Amel, et al.
Publicado: (2022)

97. Competition Experiments for the Baloxavir-Resistant I38T Influenza A Mutant
por: Checkmahomed, Liva, et al.
Publicado: (2019)

Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014
por: Seleka, Mpho, et al.
Publicado: (2017)

The Epidemiology and Burden of Influenza B/Victoria and B/Yamagata Lineages in Kenya, 2012–2016
por: Emukule, Gideon O, et al.
Publicado: (2019)

Cross-Lineage Influenza B and Heterologous Influenza A Antibody Responses in Vaccinated Mice: Immunologic Interactions and B/Yamagata Dominance
por: Skowronski, Danuta M., et al.
Publicado: (2012)

The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21(st) century
por: Caini, Saverio, et al.
Publicado: (2019)

Real-time RT-PCR assays for discriminating influenza B virus Yamagata and Victoria lineages
por: Nakauchi, Mina, et al.
Publicado: (2014)

Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets
por: Kiseleva, Irina, et al.
Publicado: (2018)

Substitutions near the HA receptor binding site explain the origin and major antigenic change of the B/Victoria and B/Yamagata lineages
por: Rosu, Miruna E., et al.
Publicado: (2022)

Los linajes Victoria y Yamagata de los virus gripales B, desconocidos y poco valorados
por: Reina, Jordi
Publicado: (2022)

Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model
por: Koszalka, Paulina, et al.
Publicado: (2022)

In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses
por: Checkmahomed, Liva, et al.
Publicado: (2020)

Synergistic PA and HA mutations confer mouse adaptation of a contemporary A/H3N2 influenza virus
por: Baz, Mariana, et al.
Publicado: (2019)

In Vivo Antiviral Activity of Baloxavir against PA/I38T-Substituted Influenza A Viruses at Clinically Relevant Doses
por: Kuroda, Takayuki, et al.
Publicado: (2023)

Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design
por: da Costa, Kelly A. S., et al.
Publicado: (2022)

In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors
por: Fage, Clément, et al.
Publicado: (2018)

Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada
por: Abed, Yacine, et al.
Publicado: (2019)

In vitro fitness of SARS-CoV-2 variants as assessed by competition experiments followed by ddRT-PCR and whole genome sequencing
por: Hénaut, Mathilde, et al.
Publicado: (2023)

Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model
por: Lee, Leo Y, et al.
Publicado: (2021)

Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus
por: Baz, Mariana, et al.
Publicado: (2018)

The Influenza B Virus Victoria and Yamagata Lineages Display Distinct Cell Tropism and Infection-Induced Host Gene Expression in Human Nasal Epithelial Cell Cultures
por: Wilson, Jo L., et al.
Publicado: (2023)

The Influenza B Virus Victoria and Yamagata Lineages Display Distinct Cell Tropism and Infection Induced Host Gene Expression in Human Nasal Epithelial Cell Cultures
por: Wilson, Jo L., et al.
Publicado: (2023)

A rapid pyrosequencing assay for the molecular detection of influenza viruses with reduced baloxavir susceptibility due to PA/I38X amino acid substitutions
por: Koszalka, Paulina, et al.
Publicado: (2020)

Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir
por: Mishin, Vasiliy P., et al.
Publicado: (2019)

Co-circulation of influenza A(H1N1), A(H3N2), B(Yamagata) and B(Victoria) during the 2017−2018 influenza season in Zhejiang Province, China
por: Mao, Haiyan, et al.
Publicado: (2020)

Vaccine Mismatches, Viral Circulation, and Clinical Severity Patterns of Influenza B Victoria and Yamagata Infections in Brazil over the Decade 2010–2020: A Statistical and Phylogeny–Trait Analyses
por: da Costa, Jaline Cabral, et al.
Publicado: (2022)

A Review of Clinical Influenza A and B Infections With Reduced Susceptibility to Both Oseltamivir and Zanamivir
por: Abed, Yacine, et al.
Publicado: (2017)

Predominance of influenza B/Yamagata lineage viruses in Bulgaria during the 2017/2018 season
por: Korsun, N. S., et al.
Publicado: (2019)

Extinction of the Influenza B Yamagata Line during the COVID Pandemic—Implications for Vaccine Composition
por: Vajo, Zoltan, et al.
Publicado: (2022)

A novel E198K substitution in the PA gene of influenza A virus with reduced susceptibility to baloxavir acid
por: Takizawa, Naoki, et al.
Publicado: (2022)

Has influenza B/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines?
por: Paget, John, et al.
Publicado: (2022)

Modeling mitigation of influenza epidemics by baloxavir
por: Du, Zhanwei, et al.
Publicado: (2020)

Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
por: Myers, Mallory L., et al.
Publicado: (2022)

Prophylactic Treatment with Baloxavir Protects Mice from Lethal Infection with Influenza A and B Viruses
por: Fukao, Keita, et al.
Publicado: (2023)

Effect of In Vitro Syncytium Formation on the Severity of Human Metapneumovirus Disease in a Murine Model
por: Aerts, Laetitia, et al.
Publicado: (2015)

Transmission Network of Measles During the Yamagata Outbreak in Japan, 2017
por: Kobayashi, Tetsuro, et al.
Publicado: (2022)

Ten-year longitudinal investigation of astigmatism: The Yamagata Study (Funagata)
por: Namba, Hiroyuki, et al.
Publicado: (2022)

Expanding Mouse-Adapted Yamagata-like Influenza B Viruses in Eggs Enhances In Vivo Lethality in BALB/c Mice
por: Pekarek, Matthew J., et al.
Publicado: (2022)

Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
por: Myers, Mallory L., et al.
Publicado: (2023)

Design and Validation with Influenza A Virus of an Aerosol Transmission Chamber for Ferrets
por: Turgeon, Nathalie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b36b7r0mi45nq83ipcp5ev6mlt